Founders Fund Growth Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-407,017
| Closed | -$1.2M | – | 3 |
|
|
2024
Q2 | $1.2M | Hold |
407,017
| – | – | 3.68% | 2 |
|
|
2024
Q1 | $1.84M | Hold |
407,017
| – | – | 2.94% | 2 |
|
|
2023
Q4 | $2.32M | Hold |
407,017
| – | – | 2.81% | 2 |
|
|
2023
Q3 | $1.87M | Hold |
407,017
| – | – | 5.1% | 2 |
|
|
2023
Q2 | $2.63M | Hold |
407,017
| – | – | 9.39% | 2 |
|
|
2023
Q1 | $3.07M | Hold |
407,017
| – | – | 14.23% | 2 |
|
|
2022
Q4 | $4.12M | Hold |
407,017
| – | – | 20.66% | 2 |
|
|
2022
Q3 | $4.03M | Hold |
407,017
| – | – | 11.55% | 2 |
|
|
2022
Q2 | $4.33M | Hold |
407,017
| – | – | 12.66% | 2 |
|
|
2022
Q1 | $3.97M | Hold |
407,017
| – | – | 4.48% | 3 |
|
|
2021
Q4 | $5.82M | Buy |
+407,017
| New | +$5.82M | 3.28% | 3 |
|